Quebec doctor concerned by hydroxychloroquine shortage after patients denied treatment

Click to play video: 'Coronavirus: Patients denied vital medication' Coronavirus: Patients denied vital medication
WATCH: Hydroxychloroquine has been touted as a "miracle drug" in the fight against Covid-19, but now, in Quebec, some patients are having to go without the medication to treat other conditions. Global's Anne Leclair has more. – Apr 7, 2020

It’s been touted as a “miracle drug” in the fight against COVID-19. But experts across Canada are now warning against the use of hydroxychloroquine in the treatment of the disease until further scientific research proves that it helps.

Still, thousands of Quebec patients are now being denied treatment due to an anticipated shortage of the prescription drug.

“Is it really being used in studies on COVID-19 patients, which I think would be very appropriate,” said rheumatologist Dr. Michel Zummer. “Or is it being stockpiled or used otherwise?” he asked, after 300 of his patients were contacted by their pharmacists and told they can no longer fill prescriptions for hydroxychloroquine.

Quebec pharmacists are now restricting the use of chloroquine and hydroxychloroquine after Quebec’s national institute of excellence in health and social services (INESSS) issued a collective prescription to prepare for a possible shortage of the drug.

Story continues below advertisement

It’s currently being used to treat patients with COVID-19 despite it not being approved by Health Canada for this purpose.

READ MORE: Canadian lupus patients missing critical drug after claims it treats coronavirus

“The issue is we don’t know is how long there will be this shortage of medication, if there really is a shortage of medication because we really don’t know what happened to this medication, where it went,” said Zummer.

The former Chief of Rheumatology at the Maisonneuve-Rosemont hospital and current co-chair of the Arthritis Alliance of Canada is demanding answers from INESSS and claims Quebec is the only province to have such restrictions.

Click to play video: 'FDA approves ’emergency use’ of hydroxychloroquin to test on coronavirus patients' FDA approves ’emergency use’ of hydroxychloroquin to test on coronavirus patients
FDA approves ’emergency use’ of hydroxychloroquin to test on coronavirus patients – Mar 30, 2020

“Personally I have asked questions and my association has asked questions,” said Zummer. “We don’t know what the government is doing about trying to secure more medication and when this medication will be available for our patients.”

Story continues below advertisement

A Boucherville-based pharmaceutical company, one of a handful in Canada that manufactures the medication, donated one million doses to hospitals two weeks ago in the fight against COVID-19.

[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]

The company insists production hasn’t stopped as it is deemed an essential service, and that the decision to restrict the medication was out of their hands.

READ MORE: Controversial malaria drug hydroxychloroquine tested at B.C. seniors’ home

“Right now I don’t think there’s any cause for concern for drug shortages,” said JAMP Pharma’s Bruno Mader.

“Our role is to supply the medication but we’re trusting the good judgment and training of the health-care workers to decide what to do with these medications.”

Under the current restrictions established by INESSS, only Quebec’s most vulnerable patients are allowed to access treatment, including people with systemic lupus erythematosus, pregnant women and patients under 18 with juvenile idiopathic arthritis.

Danielle Sullivan, a rheumatoid arthritis patient says she is being denied hydroxychloroquine. Courtesy Danielle Sullivan. Provided by Danielle Sullivan

A 58-year old mother of three who was diagnosed with rheumatoid arthritis nearly two decades ago claims it’s the only drug that alleviates her excruciating pain. She’s desperately trying to reach her doctor since the available alternatives for her condition don’t sound promising.

Story continues below advertisement
“Everybody is scared and everybody is stressed about this,” Danielle Sullivan told Global News. “The [doctor’s] secretary said that, yes, there is an option, but it’s a medication that’s really expensive.

“It’s about $1,000 a month so it’s not an option for me.”

According to Zummer,  patients may not have access to other promising medications since some require “special-access criteria,” meaning patients need to have active disease and symptoms which many do not when the disease is under control.

He hopes the Quebec government will soon provide answers and affordable alternatives for patients before they relapse. 

“Usually if the medication is stopped for a week or two there should not be a problem. Hydroxychloroquine is stored in the body for quite a long time,” said Zummer.

“But sooner or later, patients’ arthritis will flare.”

Sponsored content